Standing O is at it again!

New Hope: From left, Dr. Leila Tchelebi, a radiation oncology resident; Dr. Hani Ashamalla, chair person of the radiation oncology department; and Ioannis Parameritis, a medical physicist, discuss the protocol of the new non-Hodgkin’s lymphoma treatment.
Brooklyn Daily
Share on TwitterTweet
Share on Facebook

Don’t miss our updates:

Park Slope

New hope

Ever on the cutting edge, New York Methodist Hospital has initiated a new protocol for the treatment of patients with non-Hodgkin’s lymphoma. The latest breakthrough in the arsenal of fighting this disease is a tiny, but mighty, radioisotope called yttrium-90. It is particularly deadly to certain types of non-Hodgkin’s lymphoma. In combination with a type of the immunoglobulin G (IgG1) antibody, yttrium-90 can hone-in on cancer cells at the molecular level, and then administer cancer-killing radiation to those cells.

It’s a great addition to the arsenal, said Dr. Hani Ashamalla, chairwoman of radiation oncology.

“Every year, more than 15,000 Americans are diagnosed with follicular and/or low-grade non-Hodgkin’s lymphoma,” she said. “The first line of defense against this type of lymphoma is typically close monitoring and treatment with chemotherapy or anti-cancer drugs.”

However, if the patient’s cancer recurs after the initial treatment, this new therapy can be added to help prevent it from spreading, thereby giving the patient a much better chance of a cure than previous options, she added.

Dr. Alan Astrow, chief of hematology-oncology, further explained.

“With any type of treatment for cancer, ‘success’ means we achieve the best result with the fewest side effects for our patients,” he said.

Standing O salutes the hospital for being on the forefront of treatment in this deadly disease.

New York Methodist Hospital [506 Sixth St. and Eighth Avenue in Park Slope, (718) 780–3000].

Read Standing O every Thursday on!
Updated 11:48 am, January 16, 2019
Today’s news:
Share on TwitterTweet
Share on Facebook

Don’t miss our updates:

Reasonable discourse

Comments closed.

First name
Last name
Your neighborhood
Email address
Daytime phone

Your letter must be signed and include all of the information requested above. (Only your name and neighborhood are published with the letter.) Letters should be as brief as possible; while they may discuss any topic of interest to our readers, priority will be given to letters that relate to stories covered by The Brooklyn Paper.

Letters will be edited at the sole discretion of the editor, may be published in whole or part in any media, and upon publication become the property of The Brooklyn Paper. The earlier in the week you send your letter, the better.

Keep it local!

Stay in touch with your community. Subscribe to our free newsletter: